Ident. | Authors (with country if any) | Title |
---|
000001 |
S. Thobois [France] | USP30: a new promising target for Parkinson's disease? |
000019 |
Mohamed Jaber [France] | Autism is (also) a movement disorder. |
000027 |
Carole Hyacinthe [France] ; Imad Ghorayeb | Wake up with a new brain! |
000029 |
Anna Castrioto [France] ; Céline Piscicelli ; Dominic Pérennou ; Paul Krack ; Bettina Debû | The pathogenesis of Pisa syndrome in Parkinson's disease. |
000032 |
Raul Martinez-Fernandez [France] ; Anna Castrioto ; Paul Krack | Prefrontal--STN projections, the highway for emotion and cognition control. |
000034 |
Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien Carnicella | Pramipexole reverses Parkinson's disease-related motivational deficits in rats. |
000038 |
Benjamin Dehay [France] | Evidence piles Up for prion-like propagation mechanisms in synucleinopathies. |
000039 |
Mathieu Bourdenx [France] ; Benjamin Dehay ; Erwan Bezard | Down-regulating α-synuclein for treating synucleopathies. |
000040 |
Nagaraj D. Halemani [France] | Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation? |
000043 |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
000045 |
Olivier Flabeau [France] ; Wassilios G. Meissner ; Annaig Ozier ; Patrick Berger ; François Tison ; Pierre-Olivier Fernagut | Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. |
000048 |
M. Maltese [Italie] ; G. Martella [Italie] ; G. Madeo [Italie] ; I. Fagiolo [Italie] ; A. Tassone [Italie] ; G. Ponterio [Italie] ; G. Sciamanna [Italie] ; P. Burbaud [France] ; P. J. Conn [États-Unis] ; P. Bonsi [Italie] ; A. Pisani [Italie] | Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors |
000053 |
Benjamin Bessieres [France] ; Bruno Bontempi ; Olivier Nicole | Tiny light, big hope. |
000054 |
Michel Engeln [France] | Throwing some light on executive function in Parkinson's disease. |
000060 |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
000070 |
Benjamin Dehay [France] ; Marta Martinez-Vicente ; Guy A. Caldwell ; Kim A. Caldwell ; Zhenyue Yue ; Mark R. Cookson ; Christine Klein ; Miquel Vila ; Erwan Bezard | Lysosomal impairment in Parkinson's disease. |
000077 |
Marianne Benoit-Marand [France] | Dopamine neurons are multi-neurotransmitter neurons. |
000081 |
Mohamed Jaber [France] | CLARITY or the invisible brain. |
000085 |
Mathieu Bourdenx [France] | Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease. |
000105 |
Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni] | Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies |
000138 |
Benjamin Dehay [France] ; Erwan Bezard | New animal models of Parkinson's disease. |
000169 |
Anne-Sophie Rolland [France] ; Carine Karachi [France] ; Marie-Paule Muriel [France] ; Etienne C. Hirsch [France] ; Chantal François [France] | Internal pallidum and substantia nigra control different parts of the mesopontine reticular formation in primate |
000181 |
Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A tale on animal models of Parkinson's disease |
000255 |
Carine Karachi [France] ; David Grabli [France] ; Nicolas Baup [France] ; Stéphanie Mounayar [France] ; Dominique Tandé [France] ; Chantal François [France] ; Etienne C. Hirsch [France] | Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys |
000300 |
Annie Lannuzel [France] ; Merle Ruberg [France] ; Patrick P. Michel [France] | Atypical parkinsonism in the Caribbean island of Guadeloupe: Etiological role of the mitochondrial complex I inhibitor annonacin |
000321 |
Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
000370 |
Ruth H. Walker [États-Unis] ; Adrian Danek [Allemagne] ; Carol Dobson-Stone [Australie] ; Renzo Guerrini [Italie] ; Hans H. Jung [Suisse] ; Anne-Louise Lafontaine [Canada] ; Luca Rampoldi [Italie] ; François Tison [France] ; Eva Andermann [Canada] | Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes |
000383 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
000392 |
Carine Karachi [France] ; Jérôme Yelnik [France] ; Dominique Tandé [France] ; Léon Tremblay [France] ; Etienne C. Hirsch [France] ; Chantal François [France] | The pallidosubthalamic projection: An anatomical substrate for nonmotor functions of the subthalamic nucleus in primates |
000399 |
Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb [France] ; Elsa Diguet [France] ; François Tison [France] | In vivo models of multiple system atrophy |
000403 |
Günter U. Höglinger [France] ; Patrick P. Michel [France] ; Pierre Champy [France] ; Jean Feger [France] ; Etienne C. Hirsch [France] ; Merle Ruberg [France] ; Annie Lannuzel [France] | Experimental evidence for a toxic etiology of tropical parkinsonism |
000450 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
000466 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
000468 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
000475 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
000477 |
Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France] | Mechanisms of deep brain stimulation |
000479 |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats |
000486 |
J. Yelnik [France] | Functional anatomy of the basal ganglia |
000488 |
Anne-Catherine Bachoud-Lévi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France] | Fetal neural grafts for Huntington's disease: A prospective view |
000497 |
Frans Vanderwerf [Pays-Bas] ; Catherine Buisseret-Delmas [France] ; Pierre Buisseret [France] | Afferent innervation of eyelids and their connections to the superior colliculus |
000503 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain |
000513 |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice |
000528 |
Stéphane Palfi [États-Unis] ; Liza Leventhal [États-Unis] ; Christopher G. Goetz [États-Unis] ; Philippe Hantraye [France] ; Ben-Zion Roitberg [États-Unis] ; Joe Sramek [États-Unis] ; Marina Emborg [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Delayed onset of progressive dystonia following subacute 3‐nitropropionic acid treatment in Cebus apella monkeys |
000553 |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease |
000558 |
H. Widner [Suède] ; G.-L. Defer [France] | Dyskinesias assessment : From CAPIT to CAPSIT |
000562 |
Hagai Bergman ; Aeyal Raz ; Ariela Feingold ; Asaph Nini ; Israel Nelken ; Ben-Pazi Hilla ; David Hansel [France] ; Avinoam Reches | Physiology of MPTP Tremor |
000583 |
Mohamed Jaber [États-Unis, France] ; Sara Jones [États-Unis] ; Bruno Giros [États-Unis] ; Caron [États-Unis] | The dopamine transporter: A crucial component regulating dopamine transmission |
000602 |
Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France] | Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment |
000636 |
Rektor [France] ; M. Švejdová [France] ; C. Silva-Barrat [France] ; C. Menini [France] | The cholinergic system‐dependent myoclonus of the baboon papio is a reticular reflex myoclonus |
000657 |
Nieoullon [France] ; Lydia Kerkerian-Le Goff [France] | Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: Possible functional implications |
000672 |
J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |